New Drug For Myelodysplastic Syndrome (MDS)

MDS is a disease of the bone marrow characterized by anemia and abnormalities of the white blood cells and platelets. It sometimes transforms into leukemia, and, even when it does not it is difficult to treat, and, can be fatal. A new agent from Jansen Research Foundation, R11577, a farnesyl transferase inhibitor, has shown promise. In an MD Anderson study, 2 of 16 patients had complete remissions in this difficult to treat disease.

NetCancerAlert.Com will keep you updated on this and other vital subjects related to cancer and blood disorders.

Keep checking back with us at NETCANCERALERT.COM for new featured stories and for the latest FDA Approvals and Updates.

Cancer News Research Cancer Treatments treat cancer cancer treatments

Webmaster

February 26, 2002